Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jun;16(3):317-330.
doi: 10.14740/wjon2543. Epub 2025 Apr 22.

Nomograms for Predicting Overall Survival and Cancer-Specific Survival of Small Cell Carcinoma of Ovary Patients: A Retrospective Cohort Study

Affiliations

Nomograms for Predicting Overall Survival and Cancer-Specific Survival of Small Cell Carcinoma of Ovary Patients: A Retrospective Cohort Study

Chun Mei Yan et al. World J Oncol. 2025 Jun.

Abstract

Background: This study aimed to develop functional nomograms to predict overall survival (OS) and cancer-specific survival (CSS) of small cell carcinoma of ovary (SCCO).

Methods: SSCO case data were recruited retrospectively from the Surveillance, Epidemiology, and End Results (SEER) database. Nomograms were constructed to predict the probabilities of OS and CSS in SCCO patients based on independent predictors. The predictive performance of nomogram was evaluated with the concordance index (C-index), area under the curve (AUC), calibration curves, and decision curve analysis (DCA).

Results: The independent risk factors affecting the prognosis of SCCO patients were older age, lower income, surgery, chemotherapy, radiation, advanced International Federation of Gynecology and Obstetrics (FIGO) stage, and number of primary tumors. The C-index for the OS nomogram was 0.78 (95% confidence interval (CI): 0.75 - 0.82), and AUCs for 1-, 3-, and 5-year OS were 0.861, 0.807, and 0.821, respectively. The C-index for the CSS nomogram was 0.79 (95% CI: 0.76 - 0.83), and AUCs for 1-, 3-, and 5-year OS were 0.873, 0.841, and 0.864, respectively. The calibration curves indicated reasonable agreement between the observed and predicted probabilities of the OS and CSS nomograms, which indicated a good degree of confidence. According to the C-index, ROC, and DCA, the prognostic nomograms of OS and CSS showed better prediction accuracy and clinical application value for SCCO than the FIGO staging system.

Conclusions: We constructed original nomograms that provided useful prediction of OS and CSS for patients with SCCO. These models could facilitate the postoperative personalized assessment and the identification of treatment strategy.

Keywords: Cancer-specific survival; Nomogram; Overall survival; SEER; Small cell carcinoma of ovary.

PubMed Disclaimer

Conflict of interest statement

There is no conflict of interest.

Figures

Figure 1
Figure 1
Optimal cutoff values for age, year of diagnosis, and tumor size using X-tile software analysis. (a, b) The optimal cutoff values of the variable age were 45 and 72 years. (c, d) The optimal cutoff values of the variable year of diagnosis were 2002 and 2015. (e, f) The optimal cutoff values of tumor size were 92 and 141 mm.
Figure 2
Figure 2
Nomograms for predicting 1-, 3-, and 5-year survival of SCCO patients: (a) overall survival; (b) cancer-specific survival. SCCO: small cell carcinoma of ovary; FIGO: Federation International of Gynecology and Obstetrics.
Figure 3
Figure 3
ROC curve of the nomogram (a) and FIGO stage (c) for OS. ROC curve of the nomogram (b) and FIGO stage (d) for CSS. CSS: cancer-specific survival; FIGO: Federation International of Gynecology and Obstetrics; OS: overall survival; ROC: receiver operating characteristic.
Figure 4
Figure 4
Calibration curves for 1-year (a), 3-year (b), and 5-year (c) OS. Calibration curves for 1-year (d), 3-year (e), and 5-year (f) CSS. CSS: cancer-specific survival; OS: overall survival.
Figure 5
Figure 5
DCA curve of the nomogram and FIGO stage for OS (a) and CSS (b). CSS: cancer-specific survival; DCA: decision curve analysis; FIGO: Federation International of Gynecology and Obstetrics; OS: overall survival.

Similar articles

References

    1. Reed NS, Pautier P, Avall-Lundqvist E, Choi CH, du Bois A, Friedlander M, Fyles A. et al. Gynecologic Cancer InterGroup (GCIG) consensus review for ovarian small cell cancers. Int J Gynecol Cancer. 2014;24(9 Suppl 3):S30–34. doi: 10.1097/IGC.0000000000000293. - DOI - PubMed
    1. Li R, Zhou T, Chen S, Li N, Cai Z, Ling Y, Feng Z. Small cell carcinoma of the ovary, hypercalcemic type (SCCOHT): a challenge for clinicopathological diagnosis. Int J Clin Exp Pathol. 2019;12(6):2166–2172. - PMC - PubMed
    1. Munstedt K, Estel R, Dreyer T, Kurata A, Benz A. Small cell ovarian carcinomas - characterisation of two rare tumor entities. Geburtshilfe Frauenheilkd. 2013;73(7):698–704. doi: 10.1055/s-0032-1328658. - DOI - PMC - PubMed
    1. Scully RE. Small cell carcinoma of hypercalcemic type. Int J Gynecol Pathol. 1993;12(2):148–152. doi: 10.1097/00004347-199304000-00010. - DOI - PubMed
    1. Ray-Coquard I, Morice P, Lorusso D, Prat J, Oaknin A, Pautier P, Colombo N. et al. Non-epithelial ovarian cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018;29(Suppl 4):iv1–iv18. doi: 10.1093/annonc/mdy001. - DOI - PubMed

LinkOut - more resources